Johnson & Johnson
recently increased an investment in an embattled biotech stock, and slashed a position in a maker of surgical robotics that rocketed last year.
Johnson & Johnson (ticker: JNJ) more than doubled an investment in
MeiraGTx
Holdings (MGTX), and more than halved a stake in
Procept BioRobotics
(PRCT) in the fourth quarter. J&J disclosed the investment changes, among others, in a form it filed with the Securities and Exchange Commission.
Source: https://www.barrons.com/articles/jnj-biotech-stock-meiragtx-procept-2c46ad81?siteid=yhoof2&yptr=yahoo